Updated:
Changxing Pharmaceutical
Changxing Pharmaceutical was established in 1984. Chen Baohua serves as founder and chairman of its parent Zhejiang Huahai Pharmaceutical. The company...
Changxing Pharmaceutical
Changxing Pharmaceutical was established in 1984. Chen Baohua serves as founder and chairman of its parent Zhejiang Huahai Pharmaceutical. The company originated under prior ownership by Vitop Bioenergy Holdings Limited before the Huahai acquisition. The firm centers on pharmaceutical manufacturing and sales. It maintains a production site in Huzhou, Zhejiang. Geographic reach includes the Hong Kong office. Asset holdings comprise the industrial facility, commercial space in Hong Kong, and a China-based intellectual property portfolio. No external fund commitments or named co-investors appear in available records. Team details and professional count remain undisclosed. Adjacent structures include membership in the Roundtable on Sustainable Palm Oil and the China Health Care Association. The Linhai Charity Foundation operates as a related philanthropic vehicle. No operational events from the last 24 months are recorded.
General information
Firm type
Corporate Investor
Year founded
1984
Location
Region
Asia
Country
China
City
Huzhou
Corporate office
Huzhou, Zhejiang, China
Additional offices
Hong Kong
Principals
Chen Baohua
Founder and Chairman
Zhou Minghua
Business Partner
Zhao Limin
Business Partner
Sector focus
Frequently asked questions
Who controls investment decisions at Changxing Pharmaceutical?
Chen Baohua, founder and chairman of parent Zhejiang Huahai Pharmaceutical, holds primary oversight. Zhou Minghua and Zhao Limin participate as business partners in group matters.
What asset classes does Changxing Pharmaceutical deploy into?
Activity centers on pharmaceutical manufacturing assets and related intellectual property. Holdings include an industrial facility in Huzhou and commercial space in Hong Kong.
Does Changxing Pharmaceutical commit to external funds or focus on direct holdings?
Available information shows only direct ownership of operating assets and IP. No fund commitments or co-investor activity is documented.
Where does Changxing Pharmaceutical maintain operations?
Headquarters sit in Huzhou, Zhejiang, China. An additional office exists in Hong Kong.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: